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Only a small fraction of individuals infected withMycobacterium tuberculosis develop clinical tuberculosis (TB) in their lifetime. Genetic
epidemiological evidence suggests a genetic determinism of pulmonary TB (PTB), but the molecular basis of genetic predisposition to
PTB remains largely unknown. We used a positional-cloning approach to carry out ultrafine linkage-disequilibriummapping of a previ-
ously identified susceptibility locus in chromosomal region 8q12–13 by genotyping 3,216 SNPs in a family-based Moroccan sample
including 286 offspring with PTB. We observed 44 PTB-associated SNPs (p < 0.01), which were genotyped in an independent set of
317 cases and 650 controls from Morocco. A single signal, consisting of two correlated SNPs close to TOX, rs1568952 and rs2726600
(combined p ¼ 1.1 3 105 and 9.2 3 105, respectively), was replicated. Stronger evidence of association was found in individuals
who developed PTB before the age of 25 years (combined p for rs1568952 ¼ 4.4 3 108; odds ratio of PTB for AA versus AG/GG ¼
3.09 [1.99–4.78]). The association with rs2726600 (p ¼ 0.04) was subsequently replicated in PTB-affected subjects under 25 years in
a study of 243 nuclear families from Madagascar. Stronger evidence of replication in Madagascar was obtained for additional SNPs in
strong linkage disequilibrium with the two initial SNPs (p ¼ 0.003 for rs2726597), further confirming the signal. We thus identified
around rs1568952 and rs2726600 a cluster of SNPs strongly associated with early-onset PTB in Morocco and Madagascar. SNP
rs2726600 is located in a transcription-factor binding site in the 30 region of TOX, and further functional explorations will focus on
CD4 T lymphocytes.Tuberculosis (TB), caused by Mycobacterium tuberculosis,
results in 8.8 million new cases and 1.1 million deaths
each year1 and remains a major public-health problem
worldwide. One-third of the world’s population is exposed
to M. tuberculosis, and after exposure, most, but not all,
individuals become infected. About 5% of infected indi-
viduals develop clinical TB within 2 years of infection
and experience a minimal latency phase or none at all.
This ‘‘primary’’ TB is particularly common in children
and is often associated with aggressive miliary and/or ex-
trapulmonary disease. Other individuals remain infected
in a state of immunological equilibrium of variable dura-
tion, and most (~95%) maintain a latency of infection of
indefinite duration.2,3 The remaining 5% of infected indi-
viduals develop clinical TB later in life, typically pulmo-
nary TB (PTB) due to reactivation of the original infection
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The AmeTB is therefore characterized by great interindividual
variability at the initial infection step and at the junctures
leading to clinical symptoms of either primary TB or
reactivation PTB.2 In addition to environmental (e.g.,
microbial) and nongenetic (e.g., acquired immunodefi-
ciency) host factors, there is considerable evidence to
suggest that host genetic control of the response to
M. tuberculosis contributes to this variability.2,3 This is the
case for the control of TB infection (e.g., as measured by
the tuberculin skin test),4–7 as shown by the recent
identification of two major loci associated with TB by
genome-wide linkage analysis.8 Evidence has also been
obtained for a genetic basis for the development of clinical
disease for both childhood TB and adult PTB.2,9–11
The study of Mendelian susceptibility to mycobacterial
disease (MSMD [MIM 209950]), a clinical disease caused
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Figure 1. Fine-Mapping Association Results for 203 Moroccan
Families with at Least One Child with PTB
Statistical significance, expressed as the –log10 of the most signifi-
cant FBAT p value from the additive, dominant, and recessive
tests, is shown against the position (in Mb) on chromosome
8 for each of 2,865 quality-control-filtered SNPs. Locations and
symbols of genes (from start to stop codons) are shown below
the chromosomal-position axis. The statistical-significance
threshold for SNP selection for genotyping in the case-control
population is indicated by a horizontal black line at p ¼ 0.01.
The two SNPs (rs1568952 and rs2726600) found to be significant
after replication in the Moroccan case-control study are indicated
by arrows.initial genetic research on severe childhood TB. Mutations
resulting in impaired IFN-g immunity have been identified
in nine genes in individuals with MSMD.2,12–15 Several
children with severe TB have been found to carry biallelic
mutations of one of these genes, IL12RB1.10,16–22 In an
attempt to estimate the proportion of severe pediatric TB
cases that are Mendelian, Boisson-Dupuis et al. found
that two out of a total of 50 cases bore biallelic mutations
in IL12RB1 after sequencing.10 We recently discovered
autosomal-dominant IL-12Rb2 deficiency in eight indi-
viduals with disseminated TB (unpublished data). More
common genetic factors of susceptibility to pediatric TB
were also identified in an association study focusing on
variants of the natural-resistance-associated macrophage
protein 1 (NRAMP1 or SLC11A1) and taking gene-environ-
ment interactions into account.23 These findings for
subjects with childhood TB provide proof of principle for
the genetic basis of TB susceptibility.
The study of genetic susceptibility to PTB has proven
more difficult, although there is considerable evidence,
particularly from twin studies, to support a major role for
human genetic factors in the development of PTB.24–27
Most classical genetic association studies investigating
PTB have focused on candidate genes, and a number of
common risk variants have been reported.9 However, few
have been satisfactorily replicated, and alleles of human
leukocyte antigen (HLA) class II28,29 and NRAMP130–32
have provided the most consistent results. Recent tran-
scriptomic analyses of peripheral-blood cells identified
a neutrophil-driven interferon-inducible transcript signa-
ture in individuals with active PTB,33 providing interesting
new candidate genes and pathways to be tested. In a recent
genome-wide association study (GWAS), only two inter-408 The American Journal of Human Genetics 92, 407–414, March 7genic SNPs with modest risk effects were identified in
samples from Ghana and The Gambia.34,35 Fewer GWASs
have been published for TB than for other common
diseases, but current data suggest an underlying heteroge-
neity in the genetic variants affecting PTB. In particular,
it seems likely that different subgroups of PTB-affected
individuals have different genetic risk factors. These
subgroups can be defined on the basis of individual factors,
such as clinical characteristics, or extrinsic factors, such as
pathogen variability.36
By genome-wide linkage analysis, we previously iden-
tified in chromosomal region 8q12–13 a locus linked to
PTB in a Moroccan study population.37 In a similar situa-
tion, the positional-cloning approach has proven success-
ful in the study of genetic susceptibility to leprosy, the
second most prevalent human mycobacterial infection,
leading to the identification of susceptibility variants in
PARK2/PACRG,38 LTA,39 and the HLA class I region.40
Here, we conducted a TB association study involving two
independent study populations from Morocco and one
from Madagascar. The sampling of all the cohorts was
approved by the appropriate ethical committees and/or
institutional review boards, and written informed consent
was obtained from all adults and from the parents of
minors. We first conducted a dense fine-mapping study
of 8q12–13 by selecting and genotyping 3,216 SNPs
covering the linkage region from 55.1–61.2 Mb in human
assembly GRCh37.p5 (Figure S1, available online) in a
primary Moroccan family-based sample including 203
nuclear families with 286 PTB-affected offspring (Tables
S1 and S2). In total, we tested 2,865 quality-control-filtered
SNPs for association in family-based association tests
(FBATs) (Figure S1).
The results of this first screen are shown in Figure 1. A
p value below 0.01 was obtained for 44 SNPs (Table S3),
which were selected for replication and genotyped in a
second independent sample of 317 cases and 650 controls
from Morocco (Table S2). Forty of these 44 SNPs passed
quality-control filters. A SNP was replicated if the associa-
tion analysis yielded a one-tailed p value < 0.01 under
the same genetic model of inheritance for the same risk
allele as in the primary study. Under the assumption of
a recessive model for the minor allele, only two SNPs,
rs1568952 (G/A) and rs2726600 (A/G), satisfied this con-
dition with p values of 0.0003 and 0.0046, respectively
(Table 1). We observed that the odds ratios (ORs) were
slightly lower in the replication sample than in the
family-based sample (Table S4), which might be the result
of the ‘‘winner’s curse’’ phenomenon,41 although minor
misclassification of controls cannot be excluded (Table
S2). The minor alleles of rs1568952 (A) and rs2726600
(G) had frequencies of 0.33 and 0.36, respectively, in the
control population. With a pairwise R2 of 0.77, these
SNPs were in strong linkage disequilibrium (LD), indicative
of a single association signal. SNP rs2726600 is located
within the eighth intron of TOX, whereas rs1568952 is
located 6 kb downstream of the last TOX exon (Figure 2)., 2013
Table 1. Genetic Association Results for Replicated SNPs rs1568952 and rs2726600 in the Primary Moroccan Family-Based Study, the
Moroccan Case-Control Replication Study, and Combined Analyses under the Recessive Model for the Minor Allele
Stratum SNP
Minor
Allele
Major
Allele MAFa
Family-Based Study Case-Control Study Combined
OR (95% CI) p Valueb OR (95% CI) p Valueb OR (95% CI) p Valueb
Full rs1568952 A G 0.36 3.21 (1.41–7.35) 0.007 1.98 (1.33–2.94) 6 3 104 2.18 (1.53–3.10) 1.1 3 105
rs2726600 G A 0.40 2.65 (1.27–5.56) 0.0093 1.61 (1.12–2.31) 0.0092 1.81 (1.34–2.43) 9.2 3 105
<25 Years rs1568952 A G - 5.54 (1.97–15.53) 0.0003 2.86 (1.72–4.77) 2.9 3 105 3.09 (1.99–4.78) 4.4 3 108
rs2726600 G A - 2.56 (1.37–4.80) 0.0025 2.00 (1.24–3.23) 0.0039 2.19 (1.52–3.14) 3.2 3 105
R25 Years rs1568952 A G - 0.65 (0.12–3.66) 0.62 1.52 (0.93–2.47) 0.094 1.42 (0.88–2.27) 0.15
rs2726600 G A - 1.73 (0.56–5.33) 0.33 1.38 (0.89–2.14) 0.15 1.42 (0.95–2.13) 0.09
The following abbreviations are used: MAF, minor allele frequency; OR, odds ratio; and CI, confidence interval.
aMAF was estimated from among 316 founders.
bAll p values are two sided.We then estimated the overall effect of these two SNPs
in the combinedMoroccan samples. The combined sample
of 603 PTB-affected subjects consisting of affected
offspring from the family-based study and cases from the
case-control replication study had a sex ratio (male/female)
of 1.71 and a mean (5SD) age at the diagnosis of PTB of
25.3 (510.4) years (Table S2). The distributions of age by
study and affection status are shown in Figure S2. In
a conditional-logistic-regression analysis (Table S4), the
association-test p values for the whole sample were 1.1 3
105 for rs1568952 and 9.2 3 105 for rs2726600. The
overall OR of developing PTB at rs1568952 for AA homo-
zygous subjects versus those with an AG/GG genotype
was 2.18 (1.53–3.10). Similar results were obtained in a clas-
sical meta-analysis, further validating the conditional-
logistic-regression approach. We were also able to show
the absence of significant heterogeneity between the ORs
obtained in our family-based and case-control samples
(Table S5). Two classical factors known to influence the
occurrence of PTB are sex and age, and the association
between PTB and SNPs rs1568952 and rs2726600 was
thus examined after stratification for these two factors.
This stratification had no significant effect on the results
obtained in analyses stratified for sex (data not shown).
We conducted age-stratified analyses by considering two
groups of subjects of approximately equal size on the basis
of age at PTB diagnosis (<25 years orR25 years) and found
evidence of heterogeneity (Cochran’s Q p ¼ 0.019 for
rs1568952). In the combined sample, the evidence of asso-
ciation with rs1568952 was markedly stronger in younger
PTB cases (p value ¼ 4.4 3 108), giving an OR for devel-
oping PTB of 3.09 (1.99–4.78) (Table 1). By contrast, this
association was not significant in older PTB-affected
subjects. A similar pattern of strong association in younger
PTB-affected subjects was observed for rs2726600 and gave
an OR of developing PTB of 2.19 (1.52–3.14). We also
estimated the p values and ORs for younger affected indi-
viduals by classical meta-analysis, which gave very similar
results (Table S5). Finally, we examined the impact of
lowering the age cutoff from 25 to 18 years on OR esti-The Amemates for the younger stratum. Interestingly, we observed
that the effect of both SNPs clearly increased among
younger affected individuals when the cutoff was
decreased to 20 years or below (Figure S3). We conducted
additional analyses to make use of the between-family
information provided by our primary family sample (Table
S6). The expected frequency of the risk allele calculated
from our families with PTB-affected offspring under the
age of 25 years was significantly higher than that observed
in controls for both rs1568952 (0.39 versus 0.33, p ¼ 0.04)
and rs2726600 (0.43 versus 0.36, p ¼ 0.02) (Table S6). This
between-family information thus provides additional
support for the association between early-onset PTB and
SNPs rs1568952 and rs2726600.
We then investigated the LD patterns of our two associ-
ated SNPs with HapMap Release 28 Phases II and III
(August 2010) (Table S7). We identified five SNPs with
R2 values between 0.44 and 0.96 for rs1568952 and
between 0.54 and 0.76 for rs2726600 (Table S7). These
five SNPs had been genotyped in our primary family-
based sample and provided p values between 0.057 and
0.87 for association with PTB (Table S4). We successfully
imputed these SNPs in our case-control replication study
(Table S4) and performed a combined analysis of the
family-based and case-control samples. The signal was
stronger in younger subjects for all SNPs. rs2726596
and rs2726598, the two SNPs in strongest LD with
rs1568952 in the Moroccan population, yielded p values
between those for rs1568952 and rs2726600 (p ¼ 3 3
106 and 8 3 107, respectively), whereas the SNP for
which the lowest level of LD was observed (rs2252970)
was not significant in any of these analyses. However,
none of the associations tested was more significant
than that for rs1568952. We also carried out multivariable
regression analysis (Table S4) with these seven SNPs.
When the most significant SNP (rs1568952) was intro-
duced into the model, the other SNPs ceased to be signif-
icantly associated with early-onset PTB, confirming that
this association consisted of a single signal. Overall, these
analyses identified a cluster of variants associated withrican Journal of Human Genetics 92, 407–414, March 7, 2013 409
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Figure 2. Association between PTB and a Cluster of SNPs in the
30 Region of TOX
(A) Chromosomal location of the SNPs in the 8q region, from
59.496 to 60.032Mb.NSMAF and TOX are outlined in black, exons
are in blue, and the intergenic region is in gray. The direction of
transcription is indicated by the ‘‘<’’ sign. Locations of the cluster
of seven SNPs (numbered 1–7), including rs1568952 and
rs2726600, are indicated by black vertical lines in the magnified
region. The location of rs2693453, which was found to be in
strong LD with this cluster in the 1000 Genomes Project but was
not genotyped in the two study populations, is indicated by a black
dashed vertical line.
(B) LD patterns for the cluster of seven SNPs genotyped in the
Moroccan family-based study (left) and the Madagascan family-
based study (right). Pairwise R2 values for all pairs of SNPs are
given as percentages, and shading from white to black indicates
intensity (R2 ranges from 0 to 1). The two SNPs (rs1568952
and rs2726600) replicated in the Moroccan studies are numbered
in red.early-onset PTB in Morocco, and rs1568952 displayed the
strongest association.
Finally, we tested this cluster of replicated SNPs in
a family-based sample consisting of 243 nuclear families
from Madagascar (Table S8). These families included 244
offspring with PTB, a sex ratio of 1.54, and a mean
(5SD) age at TB diagnosis of 26.5 (510.0) years (Table
S2); age distributions by affection status are illustrated in
Figure S2. A single SNP (rs998791) failed but was success-
fully imputed (Table 2). The frequencies of the alleles
associated with a risk of PTB in the Moroccan studies410 The American Journal of Human Genetics 92, 407–414, March 7(frequencies ~0.38) were lower in the Madagascan study
population (frequencies ~0.15) than in the Moroccan pop-
ulation, decreasing the number of families informative
for FBATanalyses (Table 2). However, rs2726600 was found
to be significantly associated with PTB in the subsample of
Madagascan affected individuals with an age at diagnosis
under 25 years (p ¼ 0.042), whereas the number of infor-
mative families was too low for testing at rs1568952.
Interestingly, SNP rs2726598, which had the highest level
of LD with rs1568952 in Morocco (R2 ¼ 0.96) and
Madagascar (R2 ¼ 0.81), also tended to be associated with
PTB in younger age groups in the Madagascan sample,
although this trend was not significant (p ¼ 0.065). Two
additional SNPs, rs2726597 and rs2726596, in strong LD
with rs1568952 inMadagascar (R 2¼ 0.52 and 0.40, respec-
tively) had a minor allele frequency (MAF) (0.22) higher
than that of rs1568952 and therefore yielded a larger
number of families informative for association. These
two SNPs were significantly associated (p values of 0.003
for rs2726597 and 0.029 for rs2726596) with PTB in the
full Madagascan sample, and this association was, again,
stronger in the younger PTB-affected individuals (Table
2). For rs2726597, the OR of developing PTB before the
age of 25 years was estimated at 5.61 (1.82–17.29). Finally,
no evidence was found for an association between
rs2252970 and PTB, consistent with the results obtained
in Morocco. These results for the Madagascan sample
strongly support the association between a cluster of
SNPs around rs1568952 and rs2726600 and the develop-
ment of early-onset PTB, validating the initial findings
we obtained in Morocco.
Analyses in the two study populations from Morocco
identified rs1568952 as the SNP with the strongest
evidence for association from this cluster. However, the
low MAF and correspondingly small number of informa-
tive families, particularly for the age group under 25 years,
made it difficult to assess the effect of rs1568952 in the
Madagascan population, but the effect of rs2726600 was
replicated. The SNPs rs2726596 and rs2726597 were the
most strongly associated with PTB in the Madagascan
study, and these markers were in strong LD with
rs1568952 in both the Moroccan and Madagascan popu-
lations (Table 2) and with rs2726600 in the CEU (Utah
residents with ancestry from northern and western Europe
from the CEPH collection) population (Table S7). Refined
analysis of the cluster, including pairwise interaction
studies in the whole Moroccan sample, and haplotype
analysis in the two family-based samples from Morocco
and Madagascar did not identify any combination of
SNPs for which there was substantially stronger evidence
of association than for the best single SNP. A search
for proxy SNPs in the 1000 Genomes Project with the
web-based application SNAP42 led to the identification
of one other SNP, rs2693453, in strong LD (R2 > 0.6)
with the six associated SNPs in the CEU population (R2 ¼
0.84 with rs1568952 and 0.80 with rs2726600). SNP
rs2693453 was not released in the HapMap project and, 2013
Table 2. Genetic Association Results at rs1568952, rs2726600, and Five SNPs in Linkage Disequilibrium with rs1568952 in 243 Nuclear
Families from Madagascar under the Recessive Model for the Minor Allele
SNPa Positionb
Minor
Allele
Major
Allele MAFc R2d
Full Population Under 25 Years
n p Value OR (95% CI)e n p Value OR (95% CI)e
rs1568952 59,712,363 A G 0.14 (0.36) - 4f - - - - -
rs2726600 59,720,604 G A 0.15 (0.40) 0.57 (0.77) 10 0.065 1.79 (0.69–4.62) 8 0.042 2.68 (0.89–8.05)
rs2726598 59,713,199 A G 0.14 (0.37) 0.81 (0.96) 6 0.19 2.1 (0.52–8.4) 5 0.065 3.71 (0.80–17.14)
rs2726597 59,712,891 T G 0.22 (0.44) 0.52 (0.71) 21 0.009 2.85 (1.34–6.05) 11 0.0028 5.61 (1.82–17.29)
rs2726596 59,710,386 T C 0.22 (0.40) 0.40 (0.84) 21 0.045 1.86 (0.91–3.78) 15 0.029 2.62 (1.11–6.16)
rs2252970 59,723,371 C A 0.23 (0.46) 0.37 (0.44) 18 >0.5 - 11 >0.5 -
rs998791g 59,724,602 C T 0.12 (0.47) 0.26 (0.58) 3f - - - - -
The following abbreviations are used: MAF, minor allele frequency; OR, odds ratio; CI, confidence interval; and n, number of informative families for FBAT.
aSelected SNPs for the validation population from Madagascar were genotyped with custom-designed Illumina VeraCode GoldenGate Assays. Departures from
Hardy-Weinberg equilibrium at each marker and MAFs were calculated among founders. Replicated SNPs were tested with the use of FBATs and conditional-
logistic-regression analyses with a one-sided test and a type I error rate of 0.05.
bPosition on chromosome 8 according to human assembly GRCh37.p5 coordinates.
cValues in Morocco are in parentheses.
dPairwise R2 values with rs1568952 in Madagascar. Values in Morocco are in parentheses.
eORs and one-sided 95% CIs were derived from the one-sided family-based association test under the recessive model.
fToo few informative families to be tested.
gSNP rs99871 was imputed in the study population from Madagascar. See Table S4.is present within the span of the chromosome 8 region
defined by our cluster of associated SNPs (Figure 2). We
did not find any additional highly correlated SNPs in the
sub-Saharan African or the two Asian HapMap popu-
lations. Given the discovery of the association with PTB
in a Moroccan population very similar to the European
population in terms of MAF and LD patterns, the panel
of variants representative of our signal is probably
restricted to those identified in our cluster of six SNPs
(with the addition of rs2693453).
We then used data from the ENCODE project to investi-
gate the potential involvement of the region defined by
our SNP cluster in transcriptional regulation. The cluster
of associated SNPs overlaps the 30 region of TOX and the
downstream neighbor NSMAF (140 kb from the cluster)
(Figure 2). Our analyses strongly suggest that rs2726600
is located in an important regulatory region of ~200 bp.
This region is characterized by the presence of the
enhancer-associated histone mark (H3K4Me1) and DNase
I hypersensitivity sites in almost all cell types tested. These
sites are the strongest known predictors of transcriptional
activity43–45 and are bound by a large number of transcrip-
tion factors (e.g., NF-kB and STAT1), as shown by chro-
matin-immunoprecipitation sequencing44 (Figure S4). We
therefore explored the possible involvement of the PTB-
associated SNPs in changes to TOX and NSMAF expression
by using available data from a previous study exploring
expression quantitative trait loci in primary dendritic
cells (DCs) from 65 individuals of European descent before
and after infection with M. tuberculosis.46 Genotype
data were available for SNP rs2726600, and expression
levels for DCs showed TOX expression to be significantly
weaker (p ¼ 0.037) in the group with the at-risk homo-
zygous genotype at baseline (Figure S5), whereas NSMAFThe Ameexpression was similar across genotypes (data not shown).
These initial findings require confirmation—particularly in
other cell types, such as T cells—but they suggest that
because the SNP cluster resides in the transcription-factor
binding site, it might be involved in the modulation of
TOX expression.
We report the discovery of susceptibility variants for PTB
on the basis of a refined LD-mapping study of chromo-
somal region 8q12–13, which we previously identified as
linked with PTB in a positional-cloning strategy applied
successively to three independent samples from Morocco
and Madagascar. A cluster of six correlated SNPs was asso-
ciated with PTB, and this association was particularly
strong in subjects who were diagnosed with TB before
the age of 25 years. Some of the multiplex families from
the original linkage study37 were included in the present
study, and we found some support for the hypothesis
that the associated SNPs might in part explain the linkage
peak, although the sample size was clearly too small for
any definitive conclusions to be drawn (Table S1). The
frequencies of the PTB risk alleles for these SNPs were lower
in Madagascar than in Morocco, but we were nevertheless
able to replicate the signal supported by the two Moroccan
populations in a highly admixed Madagascan population
with source populations from Asia and Africa47 through
the use of a family-based study design robust to population
stratification. Accounting for different LD patterns across
ethnicities was shown to be critical for the validation of
SNPs in the PARKIN regulatory region associated with
leprosy in an Indian population after their discovery in
a Vietnamese population.38,48 Our results further demon-
strate the importance of carefully considering LD patterns
in the process of validating association findings across
ethnicities.rican Journal of Human Genetics 92, 407–414, March 7, 2013 411
One of the major findings of our study was the demon-
stration that the effect of this cluster of SNPs was clearly
age dependent: it was almost entirely restricted to subjects
who developed PTB before the age of 25 years. As an
example, the OR of developing PTB at rs1568952 for
homozygotes for the risk allele was 2.18 in the full popula-
tion and 3.09 in the group under 25 years old in Morocco.
In addition, when we decreased the age cutoff to 18 years,
the OR increased to 5.03, which provides further evidence
of the inverse relationship between age at diagnosis and
strength of the genetic effect (Figure S3). A similar effect
of age has already been reported for leprosy: the estimated
risk of the LTAþ80 variant is much higher in early-onset
than in late-onset leprosy subjects.39 Molecular, immuno-
logical, and clinical data, as well as other theoretical and
population-genetics considerations, have led to the devel-
opment of a theory explaining the relationship between
age at disease onset and the underlying genetic factors.49
According to this model, the genetic architecture of infec-
tious diseases is a continuous spectrum extending from
the role of single genes with strong individual effects for
Mendelian disorders of childhood to the role of polygenic
factors with modest individual effects for complex diseases
in adults. The general idea is that in areas in which a partic-
ular microbe is endemic, stronger individual genetic effects
are associated with an earlier onset of the corresponding
disease.49 The results reported here are consistent with
this hypothesis and demonstrate the strong age depen-
dence of at least some of the genetic factors underlying
susceptibility to PTB.
The cluster of associated SNPs defines a 15 kb region
overlapping the 30 region of TOX (Figure 2). SNPs
rs998791 and rs2726600 are located in introns 7 and 8 of
TOX, respectively, whereas the remaining four SNPs are
in the 30 UTR of the gene. TOX encodes the nuclear factor
thymocyte selection-associated high-mobility group box,
which is known for its role in the generation of the
immune system, including the development of T cells
and natural killer cells, and lymph node organogenesis.50
In particular, TOX is required for the development of the
CD4 T lineage.51 The high incidence of PTB in HIVþ indi-
viduals bears witness to the critical role of CD4 T cells in
maintaining immunological equilibrium after infection
withM. tuberculosis,52 and the role of T cells in mycobacte-
rial infection and disease is an area of active research.53 The
neighboring downstream gene, located 140 kb from the
SNP cluster, is NSMAF, which encodes the neutral sphingo-
myelinase (N-SMase)-activation-associated factor, also
known as FAN (factor associated with N-SMase activation).
FAN is an adaptor protein that binds constitutively to
TNF-R1 and has been implicated in TNF-induced gene
expression and leukocyte recruitment to inflammatory
sites.54 Treatments targeting TNF have been shown to
disrupt the immunological equilibrium of infected indi-
viduals and subsequently lead to PTB. NSMAF might
therefore also be of interest for functional exploration,
although FAN-deficient mice have been shown to be no412 The American Journal of Human Genetics 92, 407–414, March 7more susceptible than wild-type mice to infection with
several intracellular pathogens.54
The classification of PTB-affected individuals encom-
passes considerable phenotypic heterogeneity and summa-
rizes a number of events—from infection to the diagnosis
of clinical symptoms of variable nature—arising through
different mechanisms. To some extent, this might account
for the difficulties in replicating findings of genetic associ-
ation with PTB in candidate-gene studies and for the
limited insight provided by the largest GWAS reported to
date.34,35 The present study highlights the merits of alter-
native strategies, such as positional cloning, and the
importance of refining the PTB phenotype by accounting
for age at first PTB diagnosis in particular. In areas where
M. tuberculosis is endemic and where migration is negli-
gible, age at first PTB onset is clearly correlated with the
duration of the latency period. Identified here, the signal
close to TOX therefore appears to play an important role
in prompting the critical transition from infection to
active pulmonary disease. It is not yet possible to deter-
mine whether this effect influences short (i.e., <2 years
in the context of a primary infection or reinfection) or
long (i.e., >2 years in the context of a reactivation) latency
periods or both. Our results highlight the importance of
reducing phenotypic heterogeneity so that it becomes
easier to decipher the complex mechanisms involved in
the development of clinical TB.Supplemental Data
Supplemental Data include five figures and eight tables and can be
found with this article online at http://www.cell.com/AJHG.Acknowledgments
We thank all pulmonary-tuberculosis (PTB)-affected study partici-
pants and family members from Morocco and Madagascar and all
healthyMoroccan subjects for their participation in this study.We
thank the late M. Chentoufi (Centre de Diagnostic et Traitement
des Maladies Respiratoires [CDTMR] of Hay Mohammadi), I. Sen-
tissi and F. Bourkadi (CDTMR of Sale´), and F. El Bordi for recruit-
ment of PTB-affected subjects. We thank N. El Amraoui and
M. Hakam (National Blood Transfusion Center) for recruiting
healthy donors. We thank B. Rakotondrasoa and D. Rakotomana-
janahary for recruiting PTB-affected subjects and family members
in Madagascar. We thank E. Ranaivoson, J. Razananirinomenja-
nahary, B. Ravalison, D. Ramarinarisoa, and the staff at the Dis-
pensaire Anti-tuberculeux de Tananarive, as well as Professors H.
Raobijaona and N. Ravelomanana and the staff of the pediatric
units of Antananarivo hospitals, for assistance. We thank the
Centre National de Ge´notypage for carrying out the genotyping
for the initial fine-mapping screen. This work was supported by
grants from the French National Agency for Research, European
Commission (HEALTH-F3-2008-200732), European Research
Council (ERC-2010-AdG-268777), Pasteur Institute of Paris
(Progamme Transversal de Recherche PTR202), Bill and Melinda
Gates Foundation, St. Giles Foundation, Jeffrey Modell Founda-
tion and Talecris Biotherapeutics, Rockefeller University Center
for Clinical and Translational Science (5UL1RR024143-04),, 2013
Rockefeller University, and National Institute of Allergy and Infec-
tious Diseases (1R01AI089970-01 and U01AI088685). A.V.G. was
partly supported by the Fondation pour la Recherche Me´dicale
and Fondation BNP Paribas. L.B.B. is a scholar of the Fonds de la
Recherche en Sante´ du Que´bec.
Received: September 11, 2012
Revised: October 12, 2012
Accepted: January 22, 2013
Published: February 14, 2013Web Resources
The URLs for the data presented herein are as follows:
1000 Genomes Project, http://www.1000genomes.org/
ENCODE, http://genome.ucsc.edu/ENCODE/
Online Mendelian Inheritance in Man (OMIM), http://www.
omim.org
SNP Annotation and Proxy Search (SNAP), http://www.
broadinstitute.org/mpg/snap/References
1. World Health Organization. (2011). Global tuberculosis con-
trol: WHO report 2011 (France: World Health Organization).
2. Casanova, J.-L., and Abel, L. (2002). Genetic dissection of
immunity to mycobacteria: The human model. Annu. Rev.
Immunol. 20, 581–620.
3. Ernst, J.D. (2012). The immunological life cycle of tubercu-
losis. Nat. Rev. Immunol. 12, 581–591.
4. Cobat, A., Gallant, C.J., Simkin, L., Black, G.F., Stanley, K.,
Hughes, J., Doherty, T.M., Hanekom, W.A., Eley, B., Beyers,
N., et al. (2010). High heritability of antimycobacterial
immunity in an area of hyperendemicity for tuberculosis
disease. J. Infect. Dis. 201, 15–19.
5. Cobat, A., Barrera, L.F., Henao, H., Arbela´ez, P., Abel, L., Garcı´a,
L.F., Schurr, E., and Alcaı¨s, A. (2012). Tuberculin skin test
reactivity is dependent on host genetic background in Colom-
bian tuberculosis household contacts. Clin. Infect. Dis. 54,
968–971.
6. Jepson, A., Fowler, A., Banya, W., Singh, M., Bennett, S.,
Whittle, H., and Hill, A.V. (2001). Genetic regulation of
acquired immune responses to antigens of Mycobacterium
tuberculosis: A study of twins in West Africa. Infect. Immun.
69, 3989–3994.
7. Sepulveda, R.L., Heiba, I.M., Navarrete, C., Elston, R.C.,
Gonzalez, B., and Sorensen, R.U. (1994). Tuberculin reactivity
after newborn BCG immunization in mono- and dizygotic
twins. Tuber. Lung Dis. 75, 138–143.
8. Cobat, A., Gallant, C.J., Simkin, L., Black, G.F., Stanley, K.,
Hughes, J., Doherty, T.M., Hanekom, W.A., Eley, B., Jaı¨s, J.-P.,
et al. (2009). Two loci control tuberculin skin test reactivity
in an area hyperendemic for tuberculosis. J. Exp. Med. 206,
2583–2591.
9. Mo¨ller, M., andHoal, E.G. (2010). Current findings, challenges
and novel approaches in human genetic susceptibility to
tuberculosis. Tuberculosis (Edinb.) 90, 71–83.
10. Boisson-Dupuis, S., El Baghdadi, J., Parvaneh, N., Bousfiha, A.,
Bustamante, J., Feinberg, J., Samarina, A., Grant, A.V.,
Janniere, L., El Hafidi, N., et al. (2011). IL-12Rb1 deficiencyThe Amein two of fifty children with severe tuberculosis from Iran,
Morocco, and Turkey. PLoS ONE 6, e18524.
11. Alcaı¨s, A., Fieschi, C., Abel, L., and Casanova, J.-L. (2005).
Tuberculosis in children and adults: Two distinct genetic
diseases. J. Exp. Med. 202, 1617–1621.
12. Filipe-Santos, O., Bustamante, J., Chapgier, A., Vogt, G.,
de Beaucoudrey, L., Feinberg, J., Jouanguy, E., Boisson-Dupuis,
S., Fieschi, C., Picard, C., and Casanova, J.L. (2006). Inborn
errors of IL-12/23- and IFN-gamma-mediated immunity:
molecular, cellular, and clinical features. Semin. Immunol.
18, 347–361.
13. Bustamante, J., Arias, A.A., Vogt, G., Picard, C., Galicia, L.B.,
Prando, C., Grant, A.V., Marchal, C.C., Hubeau, M., Chapgier,
A., et al. (2011). Germline CYBB mutations that selectively
affect macrophages in kindreds with X-linked predisposition
to tuberculous mycobacterial disease. Nat. Immunol. 12,
213–221.
14. Hambleton, S., Salem, S., Bustamante, J., Bigley, V., Boisson-Du-
puis, S., Azevedo, J., Fortin, A., Haniffa, M., Ceron-Gutierrez, L.,
Bacon,C.M., et al. (2011). IRF8mutationsandhumandendritic-
cell immunodeficiency. N. Engl. J. Med. 365, 127–138.
15. Bogunovic, D., Byun, M., Durfee, L.A., Abhyankar, A., Sanal,
O., Mansouri, D., Salem, S., Radovanovic, I., Grant, A.V.,
Adimi, P., et al. (2012). Mycobacterial disease and impaired
IFN-g immunity in humans with inherited ISG15 deficiency.
Science 337, 1684–1688.
16. Altare, F., Durandy, A., Lammas, D., Emile, J.F., Lamhamedi, S.,
Le Deist, F., Drysdale, P., Jouanguy, E., Do¨ffinger, R., Bernau-
din, F., et al. (1998). Impairment of mycobacterial immunity
in human interleukin-12 receptor deficiency. Science 280,
1432–1435.
17. Fieschi, C., Dupuis, S., Catherinot, E., Feinberg, J., Bustamante,
J., Breiman, A., Altare, F., Baretto, R., Le Deist, F., Kayal, S., et al.
(2003). Low penetrance, broad resistance, and favorable
outcome of interleukin 12 receptor beta1 deficiency: Medical
and immunological implications. J. Exp. Med. 197, 527–535.
18. de Beaucoudrey, L., Samarina, A., Bustamante, J., Cobat, A.,
Boisson-Dupuis, S., Feinberg, J., Al-Muhsen, S., Jannie`re, L.,
Rose, Y., de Suremain, M., et al. (2010). Revisiting human
IL-12Rb1 deficiency: A survey of 141 patients from 30 coun-
tries. Medicine (Baltimore) 89, 381–402.
19. Tabarsi, P., Marjani, M., Mansouri, N., Farnia, P., Boisson-
Dupuis, S., Bustamante, J., Abel, L., Adimi, P., Casanova,
J.-L., and Mansouri, D. (2011). Lethal tuberculosis in a
previously healthy adult with IL-12 receptor deficiency.
J. Clin. Immunol. 31, 537–539.
20. Altare, F., Ensser, A., Breiman, A., Reichenbach, J., Baghdadi,
J.E., Fischer, A., Emile, J.F., Gaillard, J.L., Meinl, E., and
Casanova, J.L. (2001). Interleukin-12 receptor beta1 defi-
ciency in a patient with abdominal tuberculosis. J. Infect.
Dis. 184, 231–236.
21. Caragol, I., Raspall, M., Fieschi, C., Feinberg, J., Larrosa, M.N.,
Herna´ndez, M., Figueras, C., Bertra´n, J.-M., Casanova, J.-L.,
and Espan˜ol, T. (2003). Clinical tuberculosis in 2 of 3 siblings
with interleukin-12 receptor beta1 deficiency. Clin. Infect.
Dis. 37, 302–306.
22. Ozbek, N., Fieschi, C., Yilmaz, B.T., de Beaucoudrey, L., Demi-
rhan, B., Feinberg, J., Bikmaz, Y.E., and Casanova, J.-L. (2005).
Interleukin-12 receptor beta 1 chain deficiency in a child with
disseminated tuberculosis. Clin. Infect. Dis. 40, e55–e58.
23. Malik, S., Abel, L., Tooker, H., Poon, A., Simkin, L., Girard, M.,
Adams,G.J., Starke, J.R., Smith,K.C.,Graviss, E.A., et al. (2005).rican Journal of Human Genetics 92, 407–414, March 7, 2013 413
Alleles of the NRAMP1 gene are risk factors for pediatric tuber-
culosis disease. Proc. Natl. Acad. Sci. USA 102, 12183–12188.
24. Comstock, G.W. (1978). Tuberculosis in twins: A re-analysis of
the Prophit survey. Am. Rev. Respir. Dis. 117, 621–624.
25. van der Eijk, E.A., van de Vosse, E., Vandenbroucke, J.P., and
van Dissel, J.T. (2007). Heredity versus environment in tuber-
culosis in twins: the 1950s United Kingdom Prophit Survey Si-
monds and Comstock revisited. Am. J. Respir. Crit. Care Med.
176, 1281–1288.
26. Puffer, R.R. (1944). Familial Susceptibility to Tuberculosis: Its
Importance as a Public Health Problem (Cambridge, MA: Har-
vard University Press).
27. Dubos, R.J., and Dubos, J. (1987). The White Plague: Tubercu-
losis, Man, and Society (New Brunswick, NJ: Rutgers Univer-
sity Press).
28. Goldfeld, A.E., Delgado, J.C., Thim, S., Bozon, M.V., Uglialoro,
A.M., Turbay, D., Cohen, C., and Yunis, E.J. (1998). Associa-
tion of an HLA-DQ allele with clinical tuberculosis. JAMA
279, 226–228.
29. Delgado, J.C., Baena, A., Thim, S., and Goldfeld, A.E. (2006).
Aspartic acid homozygosity at codon 57 of HLA-DQ beta is
associated with susceptibility to pulmonary tuberculosis in
Cambodia. J. Immunol. 176, 1090–1097.
30. Bellamy, R., Ruwende, C., Corrah, T., McAdam, K.P., Whittle,
H.C., and Hill, A.V. (1998). Variations in the NRAMP1 gene
and susceptibility to tuberculosis in West Africans. N. Engl.
J. Med. 338, 640–644.
31. Greenwood, C.M., Fujiwara, T.M., Boothroyd, L.J., Miller,
M.A., Frappier, D., Fanning, E.A., Schurr, E., and Morgan, K.
(2000). Linkage of tuberculosis to chromosome 2q35 loci,
including NRAMP1, in a large aboriginal Canadian family.
Am. J. Hum. Genet. 67, 405–416.
32. Zhang, W., Shao, L., Weng, X., Hu, Z., Jin, A., Chen, S., Pang,
M., and Chen, Z.W. (2005). Variants of the natural resistance-
associated macrophage protein 1 gene (NRAMP1) are associ-
ated with severe forms of pulmonary tuberculosis. Clin.
Infect. Dis. 40, 1232–1236.
33. Berry, M.P.R., Graham, C.M., McNab, F.W., Xu, Z., Bloch,
S.A.A., Oni, T., Wilkinson, K.A., Banchereau, R., Skinner, J.,
Wilkinson, R.J., et al. (2010). An interferon-inducible neutro-
phil-driven blood transcriptional signature in human tubercu-
losis. Nature 466, 973–977.
34. Thye, T., Vannberg, F.O.,Wong, S.H., Owusu-Dabo, E., Osei, I.,
Gyapong, J., Sirugo, G., Sisay-Joof, F., Enimil, A., Chinbuah,
M.A., et al.; African TB Genetics Consortium; Wellcome Trust
Case Control Consortium. (2010). Genome-wide association
analyses identifies a susceptibility locus for tuberculosis on
chromosome 18q11.2. Nat. Genet. 42, 739–741.
35. Thye, T.,Owusu-Dabo, E., Vannberg, F.O., vanCrevel, R.,Curtis,
J., Sahiratmadja, E., Balabanova, Y., Ehmen, C., Muntau, B.,
Ruge,G., et al. (2012).Commonvariants at11p13 are associated
with susceptibility to tuberculosis. Nat. Genet. 44, 257–259.
36. Comas, I., Chakravartti, J., Small, P.M., Galagan, J., Niemann,
S., Kremer, K., Ernst, J.D., and Gagneux, S. (2010). Human
T cell epitopes of Mycobacterium tuberculosis are evolution-
arily hyperconserved. Nat. Genet. 42, 498–503.
37. Baghdadi, J.E., Orlova, M., Alter, A., Ranque, B., Chentoufi,
M., Lazrak, F., Archane, M.I., Casanova, J.-L., Benslimane, A.,
Schurr, E., and Abel, L. (2006). An autosomal dominant major
gene confers predisposition to pulmonary tuberculosis in
adults. J. Exp. Med. 203, 1679–1684.414 The American Journal of Human Genetics 92, 407–414, March 738. Mira, M.T., Alcaı¨s, A., Nguyen, V.T., Moraes, M.O., Di Flumeri,
C., Vu, H.T., Mai, C.P., Nguyen, T.H., Nguyen, N.B., Pham,
X.K., et al. (2004). Susceptibility to leprosy is associated with
PARK2 and PACRG. Nature 427, 636–640.
39. Alcaı¨s, A., Alter, A., Antoni, G., Orlova, M., Nguyen, V.T.,
Singh, M., Vanderborght, P.R., Katoch, K., Mira, M.T., Vu,
H.T., et al. (2007). Stepwise replication identifies a low-
producing lymphotoxin-alpha allele as a major risk factor
for early-onset leprosy. Nat. Genet. 39, 517–522.
40. Alter, A., Huong, N.T., Singh, M., Orlova, M., Van Thuc, N.,
Katoch, K., Gao, X., Thai, V.H., Ba, N.N., Carrington, M.,
et al. (2011). Human leukocyte antigen class I region single-
nucleotide polymorphisms are associated with leprosy suscep-
tibility in Vietnam and India. J. Infect. Dis. 203, 1274–1281.
41. Kraft, P. (2008). Curses—winner’s and otherwise—in genetic
epidemiology. Epidemiology 19, 649–651, discussion657–658.
42. Johnson, A.D., Handsaker, R.E., Pulit, S.L., Nizzari, M.M.,
O’Donnell, C.J., and de Bakker, P.I.W. (2008). SNAP: A web-
based tool for identification and annotation of proxy SNPs
using HapMap. Bioinformatics 24, 2938–2939.
43. Degner, J.F., Pai, A.A., Pique-Regi, R., Veyrieras, J.-B., Gaffney,
D.J., Pickrell, J.K., De Leon, S., Michelini, K., Lewellen, N.,
Crawford, G.E., et al. (2012). DNase I sensitivity QTLs are
a major determinant of human expression variation. Nature
482, 390–394.
44. ENCODE Project Consortium. (2004). The ENCODE (ENCy-
clopedia Of DNA Elements) Project. Science 306, 636–640.
45. Ernst, J., Kheradpour, P., Mikkelsen, T.S., Shoresh, N., Ward,
L.D., Epstein, C.B., Zhang, X., Wang, L., Issner, R., Coyne,
M., et al. (2011). Mapping and analysis of chromatin state
dynamics in nine human cell types. Nature 473, 43–49.
46. Barreiro, L.B., Tailleux, L., Pai, A.A., Gicquel, B., Marioni, J.C.,
and Gilad, Y. (2012). Deciphering the genetic architecture of
variation in the immune response to Mycobacterium tubercu-
losis infection. Proc. Natl. Acad. Sci. USA 109, 1204–1209.
47. Tofanelli, S., Bertoncini, S., Castrı`, L., Luiselli, D., Calafell, F.,
Donati, G., and Paoli, G. (2009). On the origins and admixture
of Malagasy: New evidence from high-resolution analyses of
paternal andmaternal lineages. Mol. Biol. Evol. 26, 2109–2124.
48. Alter, A., Fava, V.M., Huong, N.T., Singh, M., Orlova, M., Van
Thuc, N., Katoch, K., Thai, V.H., Ba, N.N., Abel, L., et al.
(2013). Linkage disequilibrium pattern and age-at-diagnosis
are critical for replicating genetic associations across ethnic
groups in leprosy. Hum. Genet. 132, 107–116.
49. Alcaı¨s, A., Quintana-Murci, L., Thaler, D.S., Schurr, E., Abel, L.,
and Casanova, J.-L. (2010). Life-threatening infectious
diseases of childhood: single-gene inborn errors of immunity?
Ann. N Y Acad. Sci. 1214, 18–33.
50. Aliahmad, P., Seksenyan, A., and Kaye, J. (2012). The many
roles of TOX in the immune system. Curr. Opin. Immunol.
24, 173–177.
51. Aliahmad, P., and Kaye, J. (2008). Development of all CD4 T
lineages requiresnuclear factor TOX. J. Exp.Med.205, 245–256.
52. Rom, W.N., and Garay, S.M. (2004). Tuberculosis (Philadel-
phia: Lippincott Williams & Wilkins).
53. Cooper, A.M. (2009). T cells in mycobacterial infection and
disease. Curr. Opin. Immunol. 21, 378–384.
54. Montfort, A., de Badts, B., Douin-Echinard, V., Martin, P.G.P.,
Iacovoni, J., Nevoit, C., Therville, N., Garcia, V., Bertrand,
M.-A., Bessie`res, M.-H., et al. (2009). FAN stimulates
TNF(alpha)-induced gene expression, leukocyte recruitment,
and humoral response. J. Immunol. 183, 5369–5378., 2013
